Grant: CIHR Fellowship
Direct Payment
$66,667.00
Influence of Omega-3 Long Chain Polyunsaturated Fatty Acids and Cyclooxygenase on the Progression of Diabetic Retinopathy
FY 2008-09
Summary
Diabetic retinopathy (DR) is the most common complication of diabetes, afflicting over 90% of persons with this disease and ultimately leads to blindness. Characterized by an initial phase of vascular death, followed by deregulated neovascularization, DR presents inflammatory components. Relevantly, lipid (fat) based molecules act as effectors of inflammation and angiogenesis (new vessel formation). Particularly potent are certain long chain polyunsaturated fatty acids (LCPUFAs) such as the Omega-6, which once metabolized by the cyclooxygenase (COX) enzyme, generate pro-inflammatory/ pro-angiogenic mediators. Conversely, an anti-inflammatory and anti-angiogenic influence is found with intake of Omega-3-LCPUFAs. As LCPUFA tissue status is modified by and dependent on dietary intake, these nutrients are reasonable choices for interventions to prevent DR with foods that are not usually consumed in the Western diet.
The proposed study is designed to:
i) Evaluate the beneficial effects of diets rich in Omega-3 LCPUFA versus those rich in Omega-6 LCPUFA on DR outcome in a mouse model of DR. COX inhibition will be investigated in conjunction with above-mentioned diets.
ii) Map out mechanisms behind DR by determining for each treatment, the gene expression profile of specific factors related to lipid metabolism, inflammation and angiogenesis.
iii) Predict other complementary pharmacological interventions by defining molecular pathways involved in DR and determining if they are suppressed by Omega-3 LCPUFA rich diets. Angiogenic pathways against which drugs exist (TNFa, iNOS, VEGF, and MMP) will be tested.
We anticipate establishing the approach of lipid intervention in DR and finding new lipid-based compounds as surrogate markers of disease. The potential impact of this work on DR is great since nutritional interventions are safe, inexpensive and readily put into practice.
Department
Program
CIHR Fellowship
Recipient
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
173251
Name
Sapieha Przemyslaw (Mike) S
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Influence of Omega-3 Long Chain Polyunsaturated Fatty Acids and Cyclooxygenase on the Progression of Diabetic Retinopathy
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$66,667
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Angiogenesis; Cyclooxygenase 2; Diabetes; Omega-3 Fatty Acid; Retinopathy; Translational Research
Abstract
Diabetic retinopathy (DR) is the most common complication of diabetes, afflicting over 90% of persons with this disease and ultimately leads to blindness. Characterized by an initial phase of vascular death, followed by deregulated neovascularization, DR presents inflammatory components. Relevantly, lipid (fat) based molecules act as effectors of inflammation and angiogenesis (new vessel formation). Particularly potent are certain long chain polyunsaturated fatty acids (LCPUFAs) such as the Omega-6, which once metabolized by the cyclooxygenase (COX) enzyme, generate pro-inflammatory/ pro-angiogenic mediators. Conversely, an anti-inflammatory and anti-angiogenic influence is found with intake of Omega-3-LCPUFAs. As LCPUFA tissue status is modified by and dependent on dietary intake, these nutrients are reasonable choices for interventions to prevent DR with foods that are not usually consumed in the Western diet.
The proposed study is designed to:
i) Evaluate the beneficial effects of diets rich in Omega-3 LCPUFA versus those rich in Omega-6 LCPUFA on DR outcome in a mouse model of DR. COX inhibition will be investigated in conjunction with above-mentioned diets.
ii) Map out mechanisms behind DR by determining for each treatment, the gene expression profile of specific factors related to lipid metabolism, inflammation and angiogenesis.
iii) Predict other complementary pharmacological interventions by defining molecular pathways involved in DR and determining if they are suppressed by Omega-3 LCPUFA rich diets. Angiogenic pathways against which drugs exist (TNFa, iNOS, VEGF, and MMP) will be tested.
We anticipate establishing the approach of lipid intervention in DR and finding new lipid-based compounds as surrogate markers of disease. The potential impact of this work on DR is great since nutritional interventions are safe, inexpensive and readily put into practice.
Competitiondate
200810
Approvedterm2
1 yr 4 mths
Pinamesdelim
Sapieha, Przemyslaw (Mike) S
Approvedterm
1 an 4 mois
Cihrcontribution2
~ $66,667~ $0~